In addition, we also showed a significant positive correlation between some clinical and laboratory variables, including dyslipidemia and the levels of IL-6 and resistin which are adipocytokines that may contribute to insulin resistance and to the development of inflammatory responses. This evidence concerns the gene RETN and Insulin resistance.